## MHK: Mohawk Industries, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.93 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-6.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($104.49)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Mohawk Industries (MHK) insider Suzanne Helen discloses $115â€“$117 share sales**
- Source: Stock Titan | 20251203T220300 | Somewhat-Bearish | Relevance: 100%
- Mohawk Industries insider Suzanne Helen indirectly sold 1,000 shares of MHK common stock in early December 2025 through a trust. The sales occurred at weighted average prices of $116.67 and $115.11. After these transactions, the trust holds 78,243 shares, and Helen also reported 141,646 shares held by a family limited partnership.

**2. Fitch Affirms Mohawk Industries' IDR at 'BBB+'; Outlook Stable**
- Source: TradingView | 20251203T174656 | Somewhat-Bullish | Relevance: 100%
- Fitch Ratings has affirmed Mohawk Industries, Inc.'s Long-Term Issuer Default Rating (IDR) and unsecured debt ratings at 'BBB+', with a Stable Outlook. This affirmation reflects Mohawk's strong market position, conservative capital allocation, and strong credit metrics, despite expectations of a subdued demand environment in the near future. Fitch anticipates Mohawk's credit metrics will remain stable and within sensitivity levels for the 'BBB+' IDR.

**3. Mohawk Industries (NYSE:MHK) Given New $125.00 Price Target at Wells Fargo & Company**
- Source: MarketBeat | 20251205T160134 | Somewhat-Bearish | Relevance: 100%
- Wells Fargo & Company has lowered its price target for Mohawk Industries (NYSE:MHK) to $125.00 from $130.00, while maintaining an "equal weight" rating. This new target implies a potential upside of 10.64% from the stock's current price. Other analysts have also adjusted their targets, with the consensus rating for MHK being a "Moderate Buy" and a target price of $137.62.

**4. Suzanne Helen Sells 500 Shares of Mohawk Industries (NYSE:MHK) Stock**
- Source: MarketBeat | 20251204T231429 | Neutral | Relevance: 100%
- Suzanne Helen, an insider at Mohawk Industries (NYSE:MHK), sold 500 shares of the company's stock for $57,555 on December 3rd, reducing her holdings to 78,243 shares. This transaction comes as Mohawk Industries reported Q3 earnings that missed EPS estimates but beat revenue expectations, with Q4 2025 EPS guidance set between $1.90 and $2.00, and analysts maintaining a "Moderate Buy" rating with an average price target of $138. The shares of MHK traded at $115.32, operating within a 52-week range of $96.24 to $143.13, and the company has a market capitalization of $7.13 billion.

**5. Wells Fargo Maintains Mohawk Industries (MHK) Equal-Weight Recommendation**
- Source: Nasdaq | 20251204T120855 | Somewhat-Bullish | Relevance: 100%
- Wells Fargo has reiterated its Equal-Weight recommendation for Mohawk Industries (MHK) as of December 4, 2025. The average analyst one-year price target for MHK is $142.98, suggesting a 24.11% upside from its current price of $115.21. Institutional ownership data indicates a slight decrease in the number of funds holding MHK, though total shares owned by institutions increased.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Wells Fargo | $125 | $130 | -4% |
| 2025-11-19 | Evercore ISI Gr | $118 | $124 | -5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Wells Fargo | main | Equal-Weight |
| 2025-11-19 | Evercore ISI Gr | main | In-Line |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 15 ($1.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-1.2%)
- JPMORGAN CHASE & CO: 8.2% (+44.8%)
- Blackrock Inc.: 5.5% (-0.7%)
- Dimensional Fund Adv: 5.0% (+1.2%)
- FMR, LLC: 3.4% (+56.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Forward P/E 11.1x attractive for 11% earnings growth. Balance sheet: strong liquidity (2.2x). Analyst sentiment negative (2 target cuts vs 0 raises). Insider selling cluster ($1.9M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.8B |
| Beta | 1.24 |
| 52W Range | $96.24 - $143.13 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 11.1 |
| Current P/E | 12.4 |
| YoY Growth | 11.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.5% to -1.6% (-6.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Below SMA200 (0.96x), long-term trend not supportive. MACD histogram positive (0.94), confirming momentum. RSI neutral at 44. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.63% (CS: 40) | Neutral |
| RSI_14 | 44.4 | Neutral |
| MACD Histogram | 0.94 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 0.943x | Below |
| vs SMA200 | 0.963x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $110.69
- **Stop Loss:** $104.49 (5.6% risk)
- **Target:** $123.09 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 161
- **Position Value:** $17,821.09
- **Portfolio %:** 17.82%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-12 (Est: $1.98)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.64 | $2.67 | +1.2% |
| 2025Q2 | $2.61 | $2.77 | +6.3% |
| 2025Q1 | $1.41 | $1.52 | +8.2% |
| 2024Q4 | $1.85 | $1.95 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*